Clinical Trial Update: Study of MT-6402 in Subjects With Advanced Solid Cancer That Expresses PD-L1 [Phase 1]

View source ↗

Summary

Phase 1 study of MT-6402 in PD-L1-expressing advanced solid tumors, including non-small cell lung cancer and squamous cell carcinoma of the head and neck, has b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Solid Tumors
• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• MT-6402

Snippet

Sponsor: Molecular Templates, Inc. | Conditions: Advanced Solid Tumor, Non-small Cell Lung Cancer | Phase 1 | Status: TERMINATED